Herantis Pharma Oyj

Research Herantis Pharma Oyj (HRTIS) on Bullrun: market cap EUR 48.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHRTIS
• ExchangeHE
• CountryFinland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 48.77M
• Financial periodFY2025
• Net income-EUR 6.62M
• Free cash flow-EUR 6.10M

Valuation Snapshot

latest market cap is EUR 48.77M.

About Herantis Pharma Oyj

Herantis Pharma Oyj, a clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson's disease (PD). The company's lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein that is in phase 1b clinical trial for the treatment of PD and other neurodegenerative diseases.

Frequently asked questions

What is Herantis Pharma Oyj's market cap?

Herantis Pharma Oyj's market capitalization is EUR 48.77M.

What does Herantis Pharma Oyj do?

Herantis Pharma Oyj, a clinical stage biotechnology company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson's disease (PD).